- ADMINISTRATIVE CORE The Administrative Core of the Mayo Alzheimer's Disease Research Center (ADRC) will coordinate the overall research activities of the Center at both sites in Rochester, Minnesota, and Jacksonville, Florida. The Core will oversee the integration of the research activities of the Center in pursuing the Specific Aims. The Core will interact with program officials at the National Institute on Aging and will be responsible for personnel and financial matters. The Core will also coordinate data transfer and communications with the National Alzheimer's Coordinating Center. The Mayo ADRC has an active Pilot Project Program, and the Core will solicit applications, review them and communicate with the National Institute on Aging on selected pilot projects. The Core will also convene the External Advisory Committee for the Mayo ADRC and hold annual meetings. The Internal Steering Committee of the ADRC will be coordinated by the Administrative Core, and monthly videoconferences will be held between Rochester and Jacksonville. The Core will also oversee the activities of the three research projects and support their research missions. Ultimately, the Administrative Core will be responsible for maintaining research along the themes of the ADRC: 1) to evaluate subjects along the AD spectrum and 2) to support research projects for AD-related dementias.

Public Health Relevance

- ADMINISTRATIVE CORE Alzheimer's disease is a complex condition affecting tens of millions of people worldwide. The Mayo Alzheimer's Disease Research Center is focusing much of its effort on understanding the basis for the disease, improving diagnoses, monitoring biomarkers and exploring new potential treatments. The Administrative Core is an essential element in the Center and is responsible for coordinating the activities of the cores and projects as well as communicating with the National Institute on Aging and other Alzheimer's centers. The Core is ultimately responsible for all the research conducted in the Center.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529
Jones, David T; Knopman, David S; Graff-Radford, Jonathan et al. (2018) In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms. Neurology 90:e947-e954
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Wennberg, Alexandra M V; Lesnick, Timothy G; Schwarz, Christopher G et al. (2018) Longitudinal Association Between Brain Amyloid-Beta and Gait in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci 73:1244-1250
Wennberg, Alexandra M V; Hagen, Clinton E; Edwards, Kelly et al. (2018) Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging. Int J Geriatr Psychiatry 33:1114-1120
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Sahoo, Aradhana; Bejanin, Alexandre; Murray, Melissa E et al. (2018) TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia. J Alzheimers Dis 64:1227-1233

Showing the most recent 10 out of 1014 publications